Clinical Trials Browser

Phase 1/2 × Metastatic Pancreatic Adenocarcinoma × Oxaliplatin × Clear all

NCT01959139 2024-02-09

S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer

Phase 1/2 Completed

126 enrolled 19 charts

Gastrointestinal

Metastatic Pancreatic Adenocarcinoma